[ad_1]
“It’s been a rocket ship,” Ivy Zelman, the chief executive of Zelman & Associates, a research firm focused on the housing industry, said Wednesday.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...